Investigating the Efficacy and Safety of Diacerein in the Management of Knee Osteoarthritis with reference to its conventional management

dc.contributor.authorShrestha, Rohit
dc.contributor.authorTamrakar, Sudichhya
dc.contributor.authorKoju, Pramesh
dc.contributor.authorMaharjan, Sagar
dc.contributor.authorMalla, Subhechhya
dc.contributor.authorShrestha, Sony Shakya
dc.date.accessioned2024-03-24T05:22:25Z
dc.date.available2024-03-24T05:22:25Z
dc.date.issued2022
dc.descriptionOriginal Articleen_US
dc.description.abstractAbstract Background: Designated as a “priority disease” by World Health Organization, Osteoarthritis is the most common chronic rheumatic disease. Providing a proper treatment for Osteoarthritis is still a major public health challenge. Diacerein has been proposed as a slow acting, symptom modifying or even disease modifying drug used in Osteoarthritis having a risk-benefit ratio far better than conventionally used drugs. However, the evidence of efficacy and safety of use of Diacerein in Osteoarthritis is yet to be explored. Hence, this study attempted to investigate the efficacy and safety of Diacerein in the management of knee osteoarthritis. Methods: This is an analytical cohort study comparing Diacerein with Non-steroidal anti-inflammatory drugs for two months in the management of knee OA. Efficacy was assessed by scores of Lysholm Knee Scoring Scale, Knee injury and Osteoarthritis Outcome Score – Physical Function Short form and Western Ontario and McMaster Universities Osteoarthritis Index. Results: After two months of treatment, the post- treatment scores were significantly superior to the baseline scores in both the treatment groups (p<0.001). There were no significant differences among the post-treatment scores in two different treatment groups (p>0.05). Discoloration of urine and gastritis were the frequently reported adverse effects in Diacerein treatment group and Non-steroidal anti-inflammatory drugs treatment group respectively. Conclusions: Our findings have shown Diacerein is as effective as Non-steroidal anti-inflammatory drugs in treating knee OA patients. Diacerein was generally well tolerated, with a good safety profile. These findings indicate the need for further studies with experimental study design in larger scale. Keywords: Diacerein; Efficacy; Knee Osteoarthritis; NSAIDs; Safetyen_US
dc.identifier.citationShresthaR., TamrakarS., KojuP., MaharjanS., MallaS., & Shakya ShresthaS. (2023). Investigating the Efficacy and Safety of Diacerein in the Management of Knee Osteoarthritis with reference to its conventional management. Journal of Nepal Health Research Council, 20(4), 942-946. https://doi.org/10.33314/jnhrc.v20i4.4323en_US
dc.identifier.issnPrint ISSN: 1727-5482; Online ISSN: 1999-6217
dc.identifier.urihttps://hdl.handle.net/20.500.14572/44
dc.language.isoenen_US
dc.publisherGovernment of Nepal; Nepal Health Research Council; Ramshah Path, Kathmandu, Nepalen_US
dc.relation.ispartofseriesOct-Dec, 2022;4323
dc.subjectDiacereinen_US
dc.subjectEfficacyen_US
dc.subjectKnee Osteoarthritisen_US
dc.subjectNSAIDsen_US
dc.subjectSafetyen_US
dc.titleInvestigating the Efficacy and Safety of Diacerein in the Management of Knee Osteoarthritis with reference to its conventional managementen_US
dc.typeJournal Articleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
4323-Manuscript-32175-1-10-20230720.pdf
Size:
337.51 KB
Format:
Adobe Portable Document Format
Description:
Fulltext.
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: